Aimmune Therapeutics, Inc. (AIMT) financial statements (2022 and earlier)

Company profile

Business Address 8000 MARINA BOULEVARD
BRISBANE, CA 94005-1884
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:158,200303,900182,400282,500191,835
Cash and cash equivalents79,880107,51173,487124,01076,677
Short-term investments63,633196,421108,943124,921115,158
Other undisclosed cash, cash equivalents, and short-term investments14,687(32)(30)33,569 
Other undisclosed current assets(9,123)8,7196,711(30,820)5,622
Total current assets:149,077312,619189,111251,680197,457
Noncurrent Assets
Operating lease, right-of-use asset11,512
Property, plant and equipment28,60426,32817,20510,3912,702
Long-term investments and receivables14,661  33,6027,992
Long-term investments14,661  33,6027,992
Other undisclosed noncurrent assets5156086183,1164,210
Total noncurrent assets:55,29226,93617,82347,10914,904
TOTAL ASSETS:204,369339,555206,934298,789212,361
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45,16837,97726,57311,3484,981
Accounts payable13,8828,8335,0951,4271,863
Accrued liabilities31,28629,14421,4789,9213,118
Debt2,257    
Other liabilities233526102117
Total current liabilities:47,44838,01226,59911,4505,098
Noncurrent Liabilities
Long-term debt and lease obligation51,552    
Long-term debt, excluding current maturities41,028    
Operating lease, liability10,524
Liabilities, other than long-term debt1,3452,5962,5301,3671,012
Other liabilities1,3452,5962,5301,3671,012
Total noncurrent liabilities:52,8972,5962,5301,3671,012
Total liabilities:100,34540,60829,12912,8176,110
Stockholders' equity
Stockholders' equity attributable to parent104,024298,947177,805285,972206,251
Common stock66554
Additional paid in capital828,618775,283443,390420,151259,668
Accumulated other comprehensive income (loss)80(108)(108)(27)(88)
Accumulated deficit(724,680)(476,234)(265,482)(134,157)(53,333)
Total stockholders' equity:104,024298,947177,805285,972206,251
TOTAL LIABILITIES AND EQUITY:204,369339,555206,934298,789212,361

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses(249,804)(215,341)(133,274)(81,527)(35,997)
Operating loss:(249,804)(215,341)(133,274)(81,527)(35,997)
Nonoperating income6,939 2,005703217
Investment income, nonoperating5,851    
Other nonoperating income1,088 2,005703217
Interest and debt expense(4,916)   (36)
Loss from continuing operations before equity method investments, income taxes:(247,781)(215,341)(131,269)(80,824)(35,816)
Other undisclosed income from continuing operations before income taxes 4,650   
Loss from continuing operations before income taxes:(247,781)(210,691)(131,269)(80,824)(35,816)
Income tax expense (benefit)(716)(61)(56) 7,029
Net loss:(248,497)(210,752)(131,325)(80,824)(28,787)
Other undisclosed net loss attributable to parent    (7,029)
Net loss available to common stockholders, diluted:(248,497)(210,752)(131,325)(80,824)(35,816)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(248,497)(210,752)(131,325)(80,824)(28,787)
Other comprehensive loss    (88)
Comprehensive loss:(248,497)(210,752)(131,325)(80,824)(28,875)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent188 (81)61(7,029)
Comprehensive loss, net of tax, attributable to parent:(248,309)(210,752)(131,406)(80,763)(35,904)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: